云南白药(000538)本期实现每股收益3.33元，营收增长10.56%，净利润增长20.08%，报告期末股东总数93944户，比上期增加52.27%，对下报告期业绩预计：不适用
云南白药：2020年第三季度报告正文
Yunnan Baiyao: Full text of the report for the third quarter of 2020
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.